US Pharma MarketingThe FDA just approved a new combination drug treatment for patients with an advanced form of breast cancer. Cancer research RFK Jr. Newsletters Log In My Account Subscribe Now My Account Settings Complete your personal information for a more tailored experience Saved Stories Billing Log Out Reporting from the frontiers of health and medicine Newsletters Log In My Account Subscribe Now Biotech Pharma Public Health Health Tech Policy Science First Opinion STAT+ STAT Events Search Log In Try STAT+ My Account My Account Settings Saved Stories Billing History Home Newsletter The Readout Lilly’s breast cancer combo wins approval Radiopharma players…
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
Hi! Today we have some consolidation in radiopharma, an early ADHD signal for orexin agonists, and a call from Reed Jobs to double NIH funding.
I like that Jobs wants biology to be treated as a space race. I also want more racing to space.
Source: STAT News Pharma